Aperio Group’s Aerie Pharmaceuticals, Inc. AERI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q4
$1.07M Buy
79,106
+9,978
+14% +$135K ﹤0.01% 1562
2020
Q3
$814K Buy
69,128
+55,684
+414% +$656K ﹤0.01% 1553
2020
Q2
$198K Sell
13,444
-221
-2% -$3.26K ﹤0.01% 2180
2020
Q1
$185K Sell
13,665
-2,770
-17% -$37.5K ﹤0.01% 2112
2019
Q4
$398K Buy
16,435
+3,166
+24% +$76.7K ﹤0.01% 1928
2019
Q3
$255K Buy
13,269
+5,496
+71% +$106K ﹤0.01% 2087
2019
Q2
$230K Sell
7,773
-1,257
-14% -$37.2K ﹤0.01% 2129
2019
Q1
$429K Buy
9,030
+2,184
+32% +$104K ﹤0.01% 1840
2018
Q4
$247K Buy
6,846
+1,591
+30% +$57.4K ﹤0.01% 2038
2018
Q3
$323K Sell
5,255
-18
-0.3% -$1.11K ﹤0.01% 1974
2018
Q2
$356K Sell
5,273
-369
-7% -$24.9K ﹤0.01% 1924
2018
Q1
$306K Sell
5,642
-79
-1% -$4.29K ﹤0.01% 1948
2017
Q4
$342K Buy
5,721
+504
+10% +$30.1K ﹤0.01% 1880
2017
Q3
$253K Buy
5,217
+303
+6% +$14.7K ﹤0.01% 2020
2017
Q2
$259K Buy
4,914
+219
+5% +$11.5K ﹤0.01% 1969
2017
Q1
$213K Buy
+4,695
New +$213K ﹤0.01% 2010